FREDERICK LEWIS ALTICE

Summary

Affiliation: Yale University
Country: USA

Publications

  1. pmc A prospective controlled trial of routine opt-out HIV testing in a men's jail
    Ravi Kavasery
    Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, Connecticut, United States of America
    PLoS ONE 4:e8056. 2009
  2. pmc Routine opt-out HIV testing strategies in a female jail setting: a prospective controlled trial
    Ravi Kavasery
    Yale University School of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, Connecticut, United States of America
    PLoS ONE 4:e7648. 2009
  3. pmc Burden of infectious diseases, substance use disorders, and mental illness among Ukrainian prisoners transitioning to the community
    Lyuba Azbel
    Ukrainian Institute on Public Health Policy, Kyiv, Ukraine
    PLoS ONE 8:e59643. 2013
  4. pmc Absence of antiretroviral therapy and other risk factors for morbidity and mortality in Malaysian compulsory drug detention and rehabilitation centers
    Jeannia J Fu
    Yale School of Medicine, Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, New Haven, Connecticut, United States of America
    PLoS ONE 7:e44249. 2012
  5. pmc Screening for drug and alcohol use disorders and their association with HIV-related sexual risk behaviors among men who have sex with men in Peru
    Kaysia T Ludford
    Yale School of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, Connecticut, United States of America
    PLoS ONE 8:e69966. 2013
  6. pmc HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study
    Frederick L Altice
    Yale University School of Medicine, New Haven, CT, USA
    J Acquir Immune Defic Syndr 56:S22-32. 2011
  7. doi request reprint Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs
    Frederick L Altice
    Department of Medicine, Section of Infectious Diseases, Yale University, New Haven, CT 06510 2283, USA
    Lancet 376:367-87. 2010
  8. ncbi request reprint The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention
    Frederick L Altice
    AIDS Program, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06510, USA
    Clin Infect Dis 43:S178-83. 2006
  9. pmc Correlates of HIV infection among incarcerated women: implications for improving detection of HIV infection
    Frederick L Altice
    Yale University, School of Medecine, New Haven, CT 06510 2283, USA
    J Urban Health 82:312-26. 2005
  10. ncbi request reprint Predictors of HIV infection among newly sentenced male prisoners
    F L Altice
    Yale University AIDS Program, New Haven, Connecticut 06510 2283, USA
    J Acquir Immune Defic Syndr Hum Retrovirol 18:444-53. 1998

Detail Information

Publications52

  1. pmc A prospective controlled trial of routine opt-out HIV testing in a men's jail
    Ravi Kavasery
    Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, Connecticut, United States of America
    PLoS ONE 4:e8056. 2009
    ..The objective of this study was to evaluate the optimal time to routinely HIV test newly incarcerated jail detainees using an opt-out strategy...
  2. pmc Routine opt-out HIV testing strategies in a female jail setting: a prospective controlled trial
    Ravi Kavasery
    Yale University School of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, Connecticut, United States of America
    PLoS ONE 4:e7648. 2009
    ..Ten million Americans enter jails annually. The objective was to evaluate new CDC guidelines for routine opt-out HIV testing and examine the optimal time to implement routine opt-out HIV testing among newly incarcerated jail detainees...
  3. pmc Burden of infectious diseases, substance use disorders, and mental illness among Ukrainian prisoners transitioning to the community
    Lyuba Azbel
    Ukrainian Institute on Public Health Policy, Kyiv, Ukraine
    PLoS ONE 8:e59643. 2013
    ..We therefore conducted a comprehensive, representative country-wide prison health survey in Ukraine, where one of the world's most volatile HIV epidemics persists, in order to address HIV prevention and treatment needs...
  4. pmc Absence of antiretroviral therapy and other risk factors for morbidity and mortality in Malaysian compulsory drug detention and rehabilitation centers
    Jeannia J Fu
    Yale School of Medicine, Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, New Haven, Connecticut, United States of America
    PLoS ONE 7:e44249. 2012
    ..Despite HIV being highly prevalent in this type of confined setting, direct evaluation of detainees with HIV and their access to medical care has yet to be reported in the literature...
  5. pmc Screening for drug and alcohol use disorders and their association with HIV-related sexual risk behaviors among men who have sex with men in Peru
    Kaysia T Ludford
    Yale School of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, Connecticut, United States of America
    PLoS ONE 8:e69966. 2013
    ..Peru's HIV epidemic is concentrated among men who have sex with men (MSM). The contribution of alcohol use disorders (AUDs) to known high-risk behaviors associated with HIV transmission in this context has not been well characterized...
  6. pmc HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study
    Frederick L Altice
    Yale University School of Medicine, New Haven, CT, USA
    J Acquir Immune Defic Syndr 56:S22-32. 2011
    ..Having opioid dependence and HIV infection are associated with poor HIV-related treatment outcomes...
  7. doi request reprint Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs
    Frederick L Altice
    Department of Medicine, Section of Infectious Diseases, Yale University, New Haven, CT 06510 2283, USA
    Lancet 376:367-87. 2010
    ..Multifaceted, interdisciplinary approaches are urgently needed to achieve parity in health outcomes in HIV-infected drug users...
  8. ncbi request reprint The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention
    Frederick L Altice
    AIDS Program, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06510, USA
    Clin Infect Dis 43:S178-83. 2006
    ..Dialogue among practitioners and policy makers in the HIV care and substance abuse communities will facilitate an effective expansion of buprenorphine and ensure that these beneficial outcomes are achieved...
  9. pmc Correlates of HIV infection among incarcerated women: implications for improving detection of HIV infection
    Frederick L Altice
    Yale University, School of Medecine, New Haven, CT 06510 2283, USA
    J Urban Health 82:312-26. 2005
    ..Alternative methods of facilitating more widespread HIV testing, such as saliva tests, rapid serologic tests, and more routine testing in high HIV-prevalence areas should be considered both for clinical and for public health benefits...
  10. ncbi request reprint Predictors of HIV infection among newly sentenced male prisoners
    F L Altice
    Yale University AIDS Program, New Haven, Connecticut 06510 2283, USA
    J Acquir Immune Defic Syndr Hum Retrovirol 18:444-53. 1998
    ..The high prevalence of HIV-seronegative inmates with self-reported high-risk behaviors also suggests the importance of prisons as sites for the introduction of appropriate risk-reduction interventions...
  11. ncbi request reprint Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication
    Frederick L Altice
    Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut 06510 2283, USA
    Clin Infect Dis 38:S376-87. 2004
    ..Moreover, DAART should incorporate enhanced elements such as convenience, flexibility, confidentiality, cues and reminders, responsive pharmacy and medical services, and specialized training for staff...
  12. pmc Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users
    Frederick L Altice
    Yale University AIDS Program, New Haven, Connecticut 06510, USA
    J Urban Health 80:416-27. 2003
    ..In addition, it demonstrates that this population can benefit from this therapy with the support of a nontraditional, community-based health intervention...
  13. pmc Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial
    Duncan Smith Rohrberg Maru
    Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, CT, USA
    J Acquir Immune Defic Syndr 50:176-81. 2009
    ....
  14. pmc Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial
    Frederick L Altice
    Yale University AIDS Program, Yale University, New Haven, CT 06510 2283, USA
    Clin Infect Dis 45:770-8. 2007
    ..Directly administered antiretroviral therapy (DAART) is one approach to improve treatment adherence among human immunodeficiency virus (HIV)-infected drug users...
  15. pmc Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy
    Duncan Smith Rohrberg Maru
    Yale University AIDS Program, 135 College Street, Suite 323, New Haven, CT 06510 2283, USA
    AIDS Behav 12:284-93. 2008
    ..The presence of depression and the lack of willingness to travel greater than four blocks to receive DAART predicted time-to-discontinuation...
  16. ncbi request reprint Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community
    Sandra A Springer
    Yale AIDS Program, Yale University School of Medicine, New Haven, Connecticut 06510 2283, USA
    Clin Infect Dis 38:1754-60. 2004
    ..More effective community-release programs are needed for incarcerated patients with HIV disease...
  17. pmc Clinical care of the HIV-infected drug user
    R Douglas Bruce
    Yale University AIDS Program, Yale University School of Medicine, New Haven, CT 06510, USA
    Infect Dis Clin North Am 21:149-79, ix. 2007
    ....
  18. ncbi request reprint Models for integrating buprenorphine therapy into the primary HIV care setting
    Sanjay Basu
    AIDS Program, Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    Clin Infect Dis 42:716-21. 2006
    ..The key barriers against effective integration of buprenorphine maintenance therapy and primary HIV services are discussed, and we suggest several mechanisms to overcome such obstacles...
  19. pmc Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services
    Laurie Sylla
    Yale University AIDS Programme, 135 College Street, Suite 323, New Haven, CT 06510, United States
    Int J Drug Policy 18:306-12. 2007
    ....
  20. ncbi request reprint Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations
    Duncan Smith Rohrberg Maru
    Yale AIDS Program, Yale University School of Medicine, New Haven, Connecticut, USA
    Clin Infect Dis 47:952-61. 2008
    ..Data are lacking on outcomes of treatment with pegylated interferon plus ribavirin (PEG-RBV) in correctional settings...
  21. doi request reprint Comparison of tuberculin skin testing reactivity in opioid-dependent patients seeking treatment with methadone versus buprenorphine: policy implications for tuberculosis screening
    Ryan K Schwarz
    Department of Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, Connecticut, USA
    Am J Drug Alcohol Abuse 35:439-44. 2009
    ..Currently, tuberculin skin testing (TST) is recommended for patients enrolling in methadone maintenance treatment (MMT), but not for those enrolling in buprenorphine maintenance treatment (BMT)...
  22. ncbi request reprint Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users
    Duncan Smith-Rohrberg
    Yale University AIDS Program, New Haven, Connecticut 06510 2283, USA
    J Acquir Immune Defic Syndr 43:S48-53. 2006
    ....
  23. pmc Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
    R Douglas Bruce
    Yale University AIDS Program, 135 College Street, Suite 323, New Haven, CT, United States
    Drug Alcohol Depend 105:234-9. 2009
    ..BUP/NLX and TPV/r should therefore be used cautiously to avoid decreased efficacy of TPV in patients taking these agents concomitantly...
  24. pmc Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: results from a randomized controlled trial
    Duncan Smith Rohrberg Maru
    Yale University AIDS Program, Yale University School of Medicine, New Haven, CT 06510 2283, USA
    J Acquir Immune Defic Syndr 46:555-63. 2007
    ..Directly administered antiretroviral therapy (DAART) is an effective intervention that improves clinical outcomes among HIV-infected drug users. Its effects on antiretroviral drug resistance, however, are unknown...
  25. doi request reprint Case series of buprenorphine injectors in Kuala Lumpur, Malaysia
    R Douglas Bruce
    AIDS Program, Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut 06510 2283, USA
    Am J Drug Alcohol Abuse 34:511-7. 2008
    ..Prospective cohort studies, rather than hospital-derived samples, are needed to better understand the safety of buprenorphine injection...
  26. ncbi request reprint Case series on the safe use of buprenorphine/naloxone in individuals with acute hepatitis C infection and abnormal hepatic liver transaminases
    Robert D Bruce
    Yale University AIDS Program, New Haven, Connecticut 06511, USA
    Am J Drug Alcohol Abuse 33:869-74. 2007
    ..Previous reports in the literature have suggested hepatotoxicity with buprenorphine tempering initial enthusiasm of the safety of buprenorphine in HCV-infected patients...
  27. pmc Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone
    David A Fiellin
    Departments of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
    J Acquir Immune Defic Syndr 56:S33-8. 2011
    ..Buprenorphine/naloxone allows the integration of opioid dependence and HIV treatment...
  28. ncbi request reprint Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir
    Robert Douglas Bruce
    Department of Medicine, Yale University AIDS Program, New Haven, CT, USA
    J Acquir Immune Defic Syndr 54:511-4. 2010
    ..This study was conducted to examine the pharmacokinetic interactions between buprenorphine/naloxone (BUP/NLX) and lopinavir/ritonavir (LPV/r) in HIV-seronegative subjects chronically maintained on BUP/NLX...
  29. pmc Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market
    R Douglas Bruce
    Yale University AIDS Program, New Haven, Connecticut, USA
    Am J Drug Alcohol Abuse 35:68-72. 2009
    ..To address this concern, co-formulation of buprenorphine/naloxone (BPN/NLX) replaced buprenorphine alone in Malaysia in December 2006...
  30. doi request reprint Preparing for highly active antiretroviral therapy rollout in rural South Africa: an assessment using the information, motivation, and behavioral skills model
    Margo D Simon
    AIDS Program, Yale University School of Medicine, New Haven, CT, USA
    AIDS Care 22:462-74. 2010
    ..Community-based assessments are urgently needed as HAART rollouts continue. Adaptation of this IMB-based survey may better inform efforts to enhance HAART-program implementation in resource-limited settings globally...
  31. pmc Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment
    SANDRA ANN SPRINGER
    Yale AIDS Program, 135 College Street, Suite 323, New Haven, CT 06510, USA
    J Urban Health 87:592-602. 2010
    ..Future randomized controlled trials are needed to affirm its benefit in this highly vulnerable population...
  32. ncbi request reprint Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice
    R Douglas Bruce
    Yale University AIDS Program, 135 College Street, New Haven, CT 06511, USA
    J Acquir Immune Defic Syndr 41:563-72. 2006
    ..Global access to opioid agonist therapy and HIV treatment is expanding but when concurrently used, problematic pharmacokinetic drug interactions can occur...
  33. pmc Pharmacological pain control for human immunodeficiency virus-infected adults with a history of drug dependence
    Sanjay Basu
    Yale University AIDS Program, Yale University School of Medicine, New Haven, CT 06511, USA
    J Subst Abuse Treat 32:399-409. 2007
    ....
  34. ncbi request reprint Managing HIV/AIDS in correctional settings
    Sandra A Springer
    Yale University School of Medicine, Yale AIDS Program, Section of Infectious Diseases, 135 College Street, Suite 323, New Haven, CT 06510, USA
    Curr HIV/AIDS Rep 2:165-70. 2005
    ....
  35. pmc Antiretroviral treatment regimen outcomes among HIV-infected prisoners
    Sandra A Springer
    Yale University AIDS Program, New Haven, CT 06510 2283, USA
    HIV Clin Trials 8:205-12. 2007
    ..Despite the high prevalence of HIV in correctional settings, the duration of therapy and response to various highly active antiretroviral therapy (HAART) regimens in this setting is unknown...
  36. pmc HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine--programme description and policy implications
    R Douglas Bruce
    Yale University AIDS Program, New Haven, CT 06510 2283, United States
    Int J Drug Policy 18:326-8. 2007
    ..Until buprenorphine maintenance therapy (BMT) was introduced, few effective strategies aimed at achieving reduction in illicit drug use were available as a conduit to anti-retroviral therapy (ARV) among IDUs...
  37. ncbi request reprint Attitudes toward and beliefs about prenatal HIV testing policies and mandatory HIV testing of newborns among drug users
    Odicie Fielder
    Yale University School of Medicine, New Haven, Connecticut, USA
    AIDS Public Policy J 20:74-91. 2005
    ..We also examined to what extent negative experiences and stigmatization affected attitudes toward HIV testing...
  38. ncbi request reprint HIV testing in correctional institutions: evaluating existing strategies, setting new standards
    Sanjay Basu
    AIDS Program, Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, in New Haven, Connecticut, USA
    AIDS Public Policy J 20:3-24. 2005
    ..Jails present added complexities because of their shorter stay with respect to prisons, and testing, treatment, and counseling policies must be adapted to these settings...
  39. pmc Adherence to hepatitis B virus vaccination at syringe exchange sites
    Frederick L Altice
    Yale University AIDS Program, 135 College Street, Suite 323, New Haven, CT 06510 2283, USA
    J Urban Health 82:151-61. 2005
    ..Trust engendered by and mutual respect afforded by such programs result in repeated encounters by active IDUs over time...
  40. ncbi request reprint Human immunodeficiency virus infection with human granulocytic ehrlichiosis complicated by symptomatic lactic acidosis
    Sandra A Springer
    Yale University AIDS Program, Yale New Haven Hospital and Yale School of Medicine, New Haven, CT, 06510 2283, USA
    Clin Infect Dis 36:e162-4. 2003
    ..To date, this is the first presentation of symptomatic hyperlactatemia in a patient with HIV infection and HGE...
  41. ncbi request reprint Observations on implementing routine HIV testing in jails
    Ravi Kavasery
    Yale University School of Medicine, Yale University AIDS Program, New Haven, Connecticut 06510 2283, USA
    AIDS Patient Care STDS 21:715-6; author reply 717. 2007
  42. ncbi request reprint Cost-effectiveness of HIV screening for incarcerated pregnant women
    Stephen Resch
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06510 2283, USA
    J Acquir Immune Defic Syndr 38:163-73. 2005
    ..In settings where HIV screening policies are not in place, however, the implementation of RPS can be expected to significantly reduce pediatric HIV cases and net health care expenditures...
  43. pmc Hepatitis B virus infection in US correctional facilities: a review of diagnosis, management, and public health implications
    Shaili Gupta
    Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, CT 06510 2283, USA
    J Urban Health 86:263-79. 2009
    ..We present a review of diagnosis, prevention, and the recently streamlined treatment guidelines for management of HBV infection in correctional settings, and discuss the implications and public health impact of these measures...
  44. doi request reprint Strategies for primary HIV prevention that target behavioral change
    Steven A Safren
    Fenway Community Health and Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Clin Infect Dis 45:S300-307. 2007
    ..Objective evidence of reductions in high-risk behavior in these 3 groups, which account for the majority of HIV transmissions in the United States, has critical implications for reducing the overall rate of new HIV infections...
  45. pmc The impact of needle exchange-based health services on emergency department use
    Harold A Pollack
    School of Public Health, University of Michigan, Ann Arbor 48109 2029, USA
    J Gen Intern Med 17:341-8. 2002
    ....
  46. ncbi request reprint Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study
    Robert S Broadhead
    Department of Sociology, University of Connecticut, Storrs 06269 2068, USA
    Soc Sci Med 55:235-46. 2002
    ..Innovative mechanisms that harness drug users' peer pressure to promote positive behavioral changes deserve greater study...
  47. ncbi request reprint HIV control efforts should directly address incarceration
    Duncan Smith Rohrberg Maru
    Lancet Infect Dis 7:568-9. 2007
  48. ncbi request reprint Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir
    R Douglas Bruce
    AIDS 20:783-4. 2006
  49. ncbi request reprint Randomized, controlled trials of directly administered antiretroviral therapy for HIV-infected patients: questions about study population and analytical approach
    Duncan Smith-Rohrberg
    Clin Infect Dis 43:1221-2; author reply 1222-3. 2006
  50. pmc Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence
    Michael M Copenhaver
    Department of Psychology, University of Connecticut, Storrs, Connecticut 06269, USA
    Am J Drug Alcohol Abuse 33:643-54. 2007
    ..Evidence points toward the use of behavioral counseling aimed at enhancing patients' motivation during treatment entry followed by an emphasis on improving coping/relapse prevention skills during the primary phase of treatment...
  51. ncbi request reprint The association between history of violence and HIV risk: a cross-sectional study of HIV-negative incarcerated women in Connecticut
    Anita Ravi
    Atlanta, GA, USA
    Womens Health Issues 17:210-6. 2007
    ....
  52. ncbi request reprint Editorial comment: why treat three conditions when it is one patient?
    R Douglas Bruce
    AIDS Read 13:378-9. 2003

Research Grants19

  1. DIRECTLY OBSERVED ANTI RETROVIRAL THERAPY AMONG ACTIVE D
    Frederick Altice; Fiscal Year: 2000
    ..Secondary measures of interest include quality of life measures, health care utilization and entry into drug treatment. ..
  2. Prison Interventions and HIV Prevention Collaboration
    FREDERICK LEWIS ALTICE; Fiscal Year: 2010
    ....
  3. Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia
    FREDERICK LEWIS ALTICE; Fiscal Year: 2010
    ....
  4. Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia
    Frederick Altice; Fiscal Year: 2009
    ....
  5. PS06-011, HIV Prevention Research with HIV+ Incarcerated Populations
    Frederick Altice; Fiscal Year: 2007
    ....
  6. Enhancing Health Outcomes Among HIV+ Substance Abusers
    Frederick Altice; Fiscal Year: 2007
    ..Therefore, if allowed the opportunity to decrease my current clinical and administrative responsibilities, I am likely to be able to achieve my short- and long-term career development goals. ..
  7. Directly Observed Therapy for Community-Released HIV-positive Prisoners
    Frederick Altice; Fiscal Year: 2007
    ..It is therefore likely that the stated aim will be successfully accomplished, despite the challenges of working with prisoners and drug-using populations. ..
  8. Improving Health Outcomes for Released HIV+ Prisoners
    Frederick Altice; Fiscal Year: 2007
    ....
  9. Direct/Observed Therapy/Community-Released HIV+Prisoners
    Frederick Altice; Fiscal Year: 2006
    ..It is therefore likely that the stated aim will be successfully accomplished, despite the challenges of working with prisoners and drug-using populations. ..
  10. Direct/Observed Therapy/Community-Released HIV+Prisoners
    Frederick Altice; Fiscal Year: 2005
    ..It is therefore likely that the stated aim will be successfully accomplished, despite the challenges of working with prisoners and drug-using populations. ..
  11. DIRECTLY OBSERVED ANTI RETROVIRAL THERAPY AMONG ACTIVE D
    Frederick Altice; Fiscal Year: 2004
    ..Secondary measures of interest include quality of life measures, health care utilization and entry into drug treatment. ..
  12. Direct/Observed Therapy/Community-Released HIV+Prisoners
    Frederick Altice; Fiscal Year: 2004
    ..It is therefore likely that the stated aim will be successfully accomplished, despite the challenges of working with prisoners and drug-using populations. ..
  13. DIRECTLY OBSERVED ANTI RETROVIRAL THERAPY AMONG ACTIVE D
    Frederick Altice; Fiscal Year: 2003
    ..Secondary measures of interest include quality of life measures, health care utilization and entry into drug treatment. ..
  14. DIRECTLY OBSERVED ANTI RETROVIRAL THERAPY AMONG ACTIVE D
    Frederick Altice; Fiscal Year: 2002
    ..Secondary measures of interest include quality of life measures, health care utilization and entry into drug treatment. ..
  15. DIRECTLY OBSERVED ANTI RETROVIRAL THERAPY AMONG ACTIVE D
    Frederick Altice; Fiscal Year: 2001
    ..Secondary measures of interest include quality of life measures, health care utilization and entry into drug treatment. ..
  16. HIV, Buprenorphine, and the Criminal Justice System
    FREDERICK LEWIS ALTICE; Fiscal Year: 2010
    ..This proposal intends to improve health to the individual and to the community during the crucial period during transition from the prison to the community. ..